- $957.11m
- $1.11bn
- $666.50m
- 65
- 43
- 84
- 69
2018 December 31st | 2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 560 | 718 | 546 | 658 | 666 |
Cost of Revenue | |||||
Gross Profit | 297 | 355 | 158 | 192 | 222 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 494 | 715 | 868 | 711 | 678 |
Operating Profit | 66.7 | 3.27 | -322 | -53 | -11.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 51.9 | -16.9 | -326 | -53.5 | -11.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 51.6 | 48.1 | -368 | -43.5 | 3.12 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 50.6 | 48.1 | -343 | 7.76 | 420 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 50.6 | 48.1 | -343 | 7.76 | 420 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.05 | 1.95 | -3.58 | -0.31 | 0.075 |